Article
Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
The journal of gene medicine - 1 May 2003
Croze France, Prud'homme Gérald J
Abstract excerpt
BACKGROUND: Despite improvements in insulin preparation and delivery, physiological normoglycemia is not easily achieved in diabetics. Therefore, there has been considerable interest in developing gene therapy approaches to supply insulin. We studied a nonviral muscle-based method of gene therapy and demonstrated that it could prevent hyperglycemia in murine streptozotocin (STZ)-induced diabetes. METHODS: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
